Paper23967355
Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin.
Kenny EF and 5 others. PLoS One, 2013. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin. Papers, record 23967355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23967355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Calmodulin | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Receptors, Antigen, B-Cell | Major topic |
| Signal Transduction | Major topic |
| Toll-Like Receptor 9 | Major topic |
| Agammaglobulinaemia Tyrosine Kinase | |
| Animals | |
| Autoimmunity | |
| Cell Line | |
| Humans | |
| Inositol 1,4,5-Trisphosphate | |
| Interleukin-6 | |
| Mice | |
| Mice, Inbred C57BL | |
| Phagosomes | |
| Phospholipase C gamma | |
| Protein Transport |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15788710 | Store-operated calcium channels. | Physiol Rev | 2005 | https://conductscience.org/library/papers/15788710 | PubMed |
| 2 | 22383797 | Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. | Blood | 2012 | https://conductscience.org/library/papers/22383797 | PubMed |
| 3 | 7797235 | The effect of IL-4 on antigen expression: a comparison of fluorescence intensity and antigen density. | Immunol Cell Biol | 1995 | https://conductscience.org/library/papers/7797235 | PubMed |
| 4 | 18513998 | The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. | Immunity | 2008 | https://conductscience.org/library/papers/18513998 | PubMed |
| 5 | 19586920 | B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19586920 | PubMed |
| 6 | 8162056 | Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. | Hum Mol Genet | 1994 | https://conductscience.org/library/papers/8162056 | PubMed |
| 7 | 14716310 | TLR9 signals after translocating from the ER to CpG DNA in the lysosome. | Nat Immunol | 2004 | https://conductscience.org/library/papers/14716310 | PubMed |
| 8 | 22434514 | TLR7 and TLR9 in SLE: when sensing self goes wrong. | Immunol Res | 2012 | https://conductscience.org/library/papers/22434514 | PubMed |
| 9 | 8332901 | Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. | Science | 1993 | https://conductscience.org/library/papers/8332901 | PubMed |
| 10 | 15716350 | Plasticity of B cell receptor internalization upon conditional depletion of clathrin. | Mol Biol Cell | 2005 | https://conductscience.org/library/papers/15716350 | PubMed |
| 11 | 18276597 | Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18276597 | PubMed |
| 12 | 20591989 | It's all about change: the antigen-driven initiation of B-cell receptor signaling. | Cold Spring Harb Perspect Biol | 2010 | https://conductscience.org/library/papers/20591989 | PubMed |
| 13 | 18434123 | Peripheral B cell subsets. | Curr Opin Immunol | 2008 | https://conductscience.org/library/papers/18434123 | PubMed |
| 14 | 15219998 | B cell antigen receptor signaling 101. | Mol Immunol | 2004 | https://conductscience.org/library/papers/15219998 | PubMed |
| 15 | 20159909 | Up-regulation of the endoplasmic reticulum transmembrane protein UNC93B in the B cells of patients with active systemic lupus erythematosus. | Rheumatology (Oxford) | 2010 | https://conductscience.org/library/papers/20159909 | PubMed |
| 16 | 16542467 | Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. | Arthritis Res Ther | 2006 | https://conductscience.org/library/papers/16542467 | PubMed |
| 17 | 6207262 | Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. | J Exp Med | 1984 | https://conductscience.org/library/papers/6207262 | PubMed |
| 18 | 20935671 | The tipping points in the initiation of B cell signalling: how small changes make big differences. | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20935671 | PubMed |
| 19 | 17344245 | Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. | Ann Rheum Dis | 2007 | https://conductscience.org/library/papers/17344245 | PubMed |
| 20 | 17964289 | Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/17964289 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40980882 | TLR9 signaling requires ligand-induced phosphorylation of two specific tyrosine residues by EGFR and Syk. | mBio | 2025 | https://conductscience.org/library/papers/40980882 | PubMed |
| 39052129 | Discordant Phenotypes of Nephritis in Patients with X-linked Agammaglobulinemia. | J Clin Immunol | 2024 | https://conductscience.org/library/papers/39052129 | PubMed |
| 38834683 | Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas. | Acta Pharmacol Sin | 2024 | https://conductscience.org/library/papers/38834683 | PubMed |
| 37835400 | Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835400 | PubMed |
| 37400550 | Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. | Nat Rev Neurol | 2023 | https://conductscience.org/library/papers/37400550 | PubMed |
| 37055617 | Bruton tyrosine kinase inhibitors for multiple sclerosis. | Nat Rev Neurol | 2023 | https://conductscience.org/library/papers/37055617 | PubMed |
| 36735294 | B cell receptor-induced IL-10 production from neonatal mouse CD19+CD43- cells depends on STAT5-mediated IL-6 secretion. | Elife | 2023 | https://conductscience.org/library/papers/36735294 | PubMed |
| 36521376 | Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy. | PLoS One | 2022 | https://conductscience.org/library/papers/36521376 | PubMed |
| 36407952 | Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/36407952 | PubMed |
| 36359789 | Aberrant B Cell Signaling in Autoimmune Diseases. | Cells | 2022 | https://conductscience.org/library/papers/36359789 | PubMed |
| 36183125 | BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36183125 | PubMed |
| 34609725 | Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease. | Drugs | 2021 | https://conductscience.org/library/papers/34609725 | PubMed |
| 34150760 | Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34150760 | PubMed |
| 34071917 | Bruton's Tyrosine Kinase Targeting in Multiple Myeloma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34071917 | PubMed |
| 33807999 | Loss of Nckx3 Exacerbates Experimental DSS-Induced Colitis in Mice through p53/NF-κB Pathway. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33807999 | PubMed |
| 33786699 | Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus. | Immunol Res | 2021 | https://conductscience.org/library/papers/33786699 | PubMed |
| 33512408 | TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. | Blood | 2021 | https://conductscience.org/library/papers/33512408 | PubMed |
| 31534009 | Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells. | J Immunol | 2019 | https://conductscience.org/library/papers/31534009 | PubMed |
| 31312202 | Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses. | Front Immunol | 2019 | https://conductscience.org/library/papers/31312202 | PubMed |
| 30761150 | Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease. | Front Immunol | 2019 | https://conductscience.org/library/papers/30761150 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23967355
GET https://conductscience.org/api/papers/v1/23967355/references?page=2